ALM-223 is under development for the treatment of systemic lupus erythematosus (SLE) and atopic dermatitis (AD). It is administered through subcutaneous route in the form of liquid. It is a fusion ...

Belantamab mafodotin is under clinical development by GSK and currently in Phase I for Systemic Lupus Erythematosus.

Geode Capital Management LLC boosted its stake in shares of Cabaletta Bio, Inc. (NASDAQ:CABA – Free Report) by 12.8% in the 3rd quarter, HoldingsChannel reports. The institutional investor owned 1,094 ...

Exagen (NASDAQ:XGN – Get Free Report) had its price target boosted by research analysts at Canaccord Genuity Group from $5.00 to $7.00 in a research report issued to clients and investors on ...

Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent ...

Ebola is a deadly hemorrhagic disease caused by a virus that is endemic in parts of East-Central and West Africa. Most people are aware that a primary route for person-to-person transmission is ...

Federal Reserve Bank of San Francisco President Mary Daly and Federal Reserve Board Governor Adriana Kugler speak as they attend the American Economics Association's annual conference, in San ...

Lupus is an autoimmune disease in which your body’s immune system attacks healthy cells and tissue. There is no cure, and the disease can pose serious, sometimes fatal complications, such as kidney ...

Two top European port visits have been dropped from an upcoming Regal Princess cruise, but guests have some time to adapt.